Jonsson Comprehensive Cancer Center
🇺🇸United States
Clinical Trials
372
Active:35
Completed:163
Trial Phases
6 Phases
Early Phase 1:17
Phase 1:109
Phase 2:114
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (336 trials with phase data)• Click on a phase to view related trials
Phase 2
114 (33.9%)Phase 1
109 (32.4%)Not Applicable
78 (23.2%)Early Phase 1
17 (5.1%)Phase 3
17 (5.1%)Phase 4
1 (0.3%)A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer
Not Applicable
Not yet recruiting
- Conditions
- Skin Carcinoma
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT07032701
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
Not Applicable
Not yet recruiting
- Conditions
- Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT06995053
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Ivonescimab for the Treatment of Thymic Cancer
Phase 2
Not yet recruiting
- Conditions
- Thymus Carcinoma
- Interventions
- Procedure: Biopsy ProcedureProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingOther: Questionnaire Administration
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT06980077
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Impact of Artificial Intelligence on Breast Cancer Screening
Not Applicable
Not yet recruiting
- Conditions
- Breast Cancer ScreeningArtificial Intelligence (AI)
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 154474
- Registration Number
- NCT06934239
- Locations
- 🇺🇸
University of California Los Angeles Health System, Los Angeles, California, United States
🇺🇸University of Washington Health System, Seattle, Washington, United States
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Phase 1
Not yet recruiting
- Conditions
- T-cell-prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory
- Interventions
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT06810778
- Locations
- 🇺🇸
David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 75
- Next
News
No news found